Joel H. Kaufman
2018
In 2018, Joel H. Kaufman earned a total compensation of $313.4K as Chief Business Officer at Navidea Biopharmaceuticals.
Compensation breakdown
Non-Equity Incentive Plan | $78,751 |
---|---|
Option Awards | $5,176 |
Salary | $225,000 |
Other | $4,493 |
Total | $313,420 |
Kaufman received $225K in salary, accounting for 72% of the total pay in 2018.
Kaufman also received $78.8K in non-equity incentive plan, $5.2K in option awards and $4.5K in other compensation.
Rankings
In 2018, Joel H. Kaufman's compensation ranked 13,070th out of 14,244 executives tracked by ExecPay. In other words, Kaufman earned more than 8.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 13,070 | 8th |
Manufacturing | 5,295 | 8th |
Chemicals And Allied Products | 1,981 | 7th |
Drugs | 1,700 | 6th |
In Vitro and In Vivo Diagnostic Substances | 62 | 14th |
Kaufman's colleagues
We found four more compensation records of executives who worked with Joel H. Kaufman at Navidea Biopharmaceuticals in 2018.
News
Navidea Biopharmaceuticals CEO Jed Latkin's 2021 pay rises 10% to $1.3M
October 24, 2022
Navidea Biopharmaceuticals CEO Jed Latkin's 2020 pay jumps 66% to $1.2M
August 2, 2021
Navidea Biopharmaceuticals CEO Jed Latkin's 2019 pay rises 16% to $740K
July 31, 2020
Navidea Biopharmaceuticals CEO Michael Goldberg's 2018 pay jumps 76% to $1.5M
June 28, 2019